ObesityPhase 3ENLIGHTEN-10NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
A Phase 3 study testing Eloralintide in people with Obesity and Overweight, run by Eli Lilly and Company at 309 sites in 21 countries.
Trial summary
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with a placebo in participants with obesity or overweight, type 2 diabetes, and increased cardiovascular risk. Read more about this study
- Who is it for?
- Ages 45 years and older
- Conditions the study is for
- Obesity, Overweight, Cardiovascular Diseases
- What is being tested?
- Eloralintide
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 3,000 participants
- Where
- 309 sitesin 21 countries
- Study dates
- Dec 2026to Dec 2029
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Have type 2 diabetes
- Have a HbA1c value between ≥ 6.5% and ≤ 9.5% at screening
- Are on stable treatment with an unchanged dose of at least 1 and no more than 4 antihyperglycemic therapies for at least 90 days before screening
- Have an increased risk of cardiovascular events
- Have a BMI ≥ 25.0 kg/m2 at screening
- Have a stable body weight (<5% body weight change) for 90 days prior to screening
- Have a history of at least one self-reported unsuccessful dietary effort to reduce body weight
Who cannot join
- Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed >1 year before screening)
- Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
- Have type 1 diabetes
- Have a history or diagnosis of New York Heart Association Functional Classification IV congestive heart failure
- Have had within 60 days prior to screening:
- acute myocardial infarction
Show all 10Show fewer
- stroke
- hospitalization for congestive heart failure, or
- coronary, peripheral, or carotid artery revascularization procedure
- Have received treatment combining sulfonylurea and insulin within 90 days prior to screening
Trial locations and contacts
309 sites in 21 countries. Contact the study team or a site near you to ask about taking part.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or contact
Physicians interested in becoming principal investigators please contact contact
309 sites in 21 countries
United States70 sites
Omega Research Orlando
Altamonte Springs, Florida, 32714
386-668-4202
Kwabena Ayesu
Amarillo Medical Specialists
Amarillo, Texas, 79124
806-358-8331
William Biggs
Smiths Medical Center
Apache Junction, Arizona, 85120
404-585-8358
Paul Olorunfemi
Virginia Nephrology Group
Arlington, Virginia, 22205
Renuka Sothinathan
Care Access - Arlington 2
Arlington, Virginia, 22206
877-791-0656
Chih Chao Yang
Care Access - Arlington Heights
Arlington Heights, Illinois, 60005
877-791-0656
Peta-Gay Jackson Booth
Southeastern Clinical Research Institute
Augusta, Georgia, 30904
7069223005
Matthew Diamond
Care Access - Baltimore
Baltimore, Maryland, 21213
877-791-0656
Peta-Gay Jackson Booth
Ascension Saint Agnes Heart Care
Baltimore, Maryland, 21229
443-798-2670
Jeffrey Cole
Central Research Associates
Birmingham, Alabama, 35205
2053271077
David Pendley
University of Alabama - Department of Nutrition Sciences
Birmingham, Alabama, 35294
205-996-4733
William Garvey
Care Access - Brandon
Brandon, Florida, 33510
813-582-7224
Parenkumar Patel
Kidney and Hypertension Center
Cincinnati, Ohio, 45212
513-861-0800
James Davis
The Corvallis Clinic, P.C.
Corvallis, Oregon, 97330
Daniel Barrett
Valley Clinical Trials, Inc.
Covina, California, 91723
310-309-9491
Linda Glaser
American Research Institute
Cutler Bay, Florida, 33157
Manuel Garcia Estrada
Renal Disease Research Institute
Dallas, Texas, 75246
2143666125
Bernard Fischbach
Nephrology Associates - East Providence
East Providence, Rhode Island, 02914
401-438-5950
Michael Thursby
Headlands Research-El Paso
El Paso, Texas, 79902
(915) 910 7088
Ryan Casey
Neighborhood Healthcare Institute of Health
Escondido, California, 92025
7607376984
Cheryl Thompson
Clinical Renal Associates, Ltd.
Exton, Pennsylvania, 19341
6108728501
Chike Okechukwu
Fleming Island Center for Clinical Research
Fleming Island, Florida, 32003
9046210390
Jennifer Sidey
Valley Institute of Research - Fort Worth
Fort Worth, Texas, 76164
8176257733
Alex Guevara
American Health Network of Indiana, LLC - Franklin
Franklin, Indiana, 46131
317-718-5479
George Cornett
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC
Gilbert, Arizona, 85296
480-691-2213
Sunildat Maheshwari
American Health Network of Indiana, LLC - Greenfield
Greenfield, Indiana, 46140
(317)462-1825
Andrew Daluga
East-West Medical Research Institute
Honolulu, Hawaii, 96814
8085316886
Cindy Pau
Biopharma Informatic, LLC
Houston, Texas, 77043
(281) 944-3610
Syed Humayun Naqvi, MD
Research Physicians Network, LLC
Houston, Texas, 77089
2819443610
Amir Hassan
Quality First Family Health/SKYCRNG
Humble, Texas, 77396
2818354449
Eli Newsome
Nephrology Consultants
Huntsville, Alabama, 35805
2565334626
Michael Quadrini
Northeast Research Institute - Downtown Office
Jacksonville, Florida, 32204
904-541-8225
David Sutton
First Valley Medical Group
Lancaster, California, 93534
661-948-6011
Kanagaratnam Sivalingam
DaVita Clinical Research - Las Vegas
Las Vegas, Nevada, 89107
7028771887
MARK VISHNEPOLSKY
Excel Clinical Research, LLC
Las Vegas, Nevada, 89109
7026801500
Robby Quintos
Lakeview Institute of Clinical Research
Leesburg, Florida, 34748
352-782-0606
Khai Chang
Ark Clinical Research
Long Beach, California, 90815
5629971000
Apinya Vutikullird
DCOL Center for Clinical Research
Longview, Texas, 75605
903-238-8854
Kathleen Harris
Biopharma Informatic, LLC
McAllen, Texas, 78503
2819443610
Gloria Ortiz, MD
Revival Research Institute, LLC
McKinney, Texas, 75071
Syed Saghir
Clinical Renal Associates Ltd.
Media, Pennsylvania, 19063
610-872-8501
Heather Mascio
Millennium Medical Research - Miami
Miami, Florida, 33126
7869538858
Aurelio Ortiz
Onhealth Research Center
Miami, Florida, 33186
Jimena Blandon
West Clinical Research
Morehead City, North Carolina, 28557
2525150050
Patrick Morgante
Southern Nh Diabetes and Endocrinology
Nashua, New Hampshire, 03063
603-577-7574
John Poremba
Lucida Clinical Trials
New Bedford, Massachusetts, 02740
508-720-2015
David Shih
York Clinical Research
Norfolk, Virginia, 23504
757-373-8478
Charles Lovell
Valley Clinical Trials, LLC dba Flourish Research
Northridge, California, 91325
818-280-4220
Christopher Chow
Advanced Research Institute
Ogden, Utah, 84405
801-409-2040
Michael Woolman
FOMAT Medical Research
Oxnard, California, 93030
805-483-1185
Augusto Focil
Renal Specialists of Houston
Pasadena, Texas, 77504
713-947-9507
Vijay Koka
Center for Diabetes, Obesity, and Metabolism
Pembroke Pines, Florida, 33024
754-888-9122
Rodolfo Galindo
Elite Clinical Studies, LLC
Phoenix, Arizona, 85018
602-788-3437
Joseph Lillo, DO
Peace River Cardiovascular Center
Port Charlotte, Florida, 33952
941-629-5356
David Hotchkiss
Eastside Research Associates
Redmond, Washington, 98052
(425) 869-6828
Christopher Price
Dominion Medical Associates, Inc.
Richmond, Virginia, 23219
8042492111
Richard Jackson
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi, 39157
601-567-1321
Bob Hutchins
Rochester Clinical Research, LLC
Rochester, New York, 14609
585-288-0890
Patrick Connors
Lake Michigan Nephrology
Saint Joseph, Michigan, 49085
269-428-0819
Oliver Songlingco
Clinical Advancement Center
San Antonio, Texas, 78212
210-223-4444
Pablo Pergola
Acclaim Clinical Research
San Diego, California, 92120
(858) 299-0009
Mitch Biermann
Care Access - Santa Clarita
Santa Clarita, California, 91321
661-371-7272
Sina Tebi
Revive Research Institute, Inc.
Southfield, Michigan, 48075
248-829-3103
Syed Raza
Clinvest Headlands Llc
Springfield, Missouri, 65807
4178837889
Cory Bethmann
Southwest Kidney Institute - Surprise
Surprise, Arizona, 85374
(480) 610-6100
Minesh Rajpal
Healthcare Research Network - Chicago
Tinley Park, Illinois, 60477
7083382245
Ronald Stumbris
Chase Medical Research, LLC
Waterbury, Connecticut, 06708
2034194420
Joseph Soufer
Millennium Clinical Trials
Westlake Village, California, 91361
805-496-3322
Razmig Krumian
Trial Management Associates - Wilmington - Floral Parkway
Wilmington, North Carolina, 28403
William Jones
Medrasa Clinical Research
Wylie, Texas, 75098
469-449-3645
Tanvir Ahmad
Argentina23 sites
CIPREC
Buenos Aires, 1061
5491144074402
Cesar Zaidman
CARDIAMET Investigaciones Médicas
Buenos Aires, C1014ACP
5491165496764
Angela Romero Zarante
Investigaciones Medicas Imoba Srl
Buenos Aires, C1056ABH
541160884234
Silvia Orio
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, C1056ABI
08003450697
Federico Perez Manghi
Centro Médico Viamonte
Buenos Aires, C1120AAC
54 1149635650
Diego Aizenberg
Mautalen Salud e Investigación
Buenos Aires, C1128AAF
541145143400
Jose Fretes
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, C1425AGC
1159054134
Mariana Scandizzo
Fundación Respirar
Buenos Aires, C1426ABP
Maria Nemesio
CEDIC
CABA, C1060ABN
541148236838
Cecilia Igarzabal
Centro Diabetológico Dr. Waitman
Córdoba, 5000
54 9 351 4245162
Silvana Ernestina Solis
Instituto de Investigaciones Clínicas Córdoba
Córdoba, X5000AAW
543514253456
Ines Bartolacci
Centro de Investigaciones Clínicas Baigorria
Granadero Baigorria, 2152
5493412106243
Juan Dominguez
CIMeL
Lanus, B1824KAJ
541142493412
Mariano Chahin
Centro de Investigaciones Médicas Mar del Plata
Mar del Plata, 7600
542234917628
Andres Alvarisqueta
Instituto de Investigaciones Clínicas Mar del Plata
Mar del Plata, B7600FZO
54 223 496 3224
Virginia Sernia
DIM Clínica Privada
Ramos Mejía, B1704ETD
54011 46562828
Oscar Montaña
INECO Neurociencias Oroño
Rosario, 2000
(0341) 425 8695
María Cappiello
Instituto Médico Catamarca IMEC
Rosario, 2000
3416176661
Natacha Maldonado
Instituto Médico Fundación Grupo Colaborativo Rosario Investigación y Prevención Medica
Rosario, 2000
543416928531
Horacio Sessa
Instituto de Investigaciones Clinicas Rosario
Rosario, S2000CVD
5493415109204
Carolina Chacón
Centro Médico Respire
San Fernando, 1646
54 9 11 47448707
Pablo Sorensen
Go Centro Medico San Nicolás
San Nicolás, 2900
5493364571637
Paulina Lanchiotti
Centro de Investigaciones Clinicas del Litoral
Santa Fe, S3000FWO
5403424562779
Miguel Hominal
China21 sites
Xuanwu Hospital Capital Medical University
Beijing, 100053
Yu Sun
Peking University Third Hospital
Beijing, 100091
13810103532
Dan Zhu
Sichuan Provincial People's Hospital
Chengdu, 610072
Limin Tian
West China Hospital, Sichuan University
Chengdu, 610041
Fang Liu
Zhujiang Hospital
Guangzhou, 510280
Haibo Long
The Second Affiliated Hospital of Zhejiang University School of Medicine - Jiefanglu Campus
Hangzhou, 310009
Xiaojie Xie
The First Hospital of Harbin Medical University
Harbin, 150001
Yue Li
Jinan Central Hospital
Jinan, 250013
Nianrong Mi
Panjin Liaoyou Baoshihua Hospital
Liaoyou, 124009
Ju Gao
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang Shi, 471003
13653880139
Hongwei Jiang
Nanjing First Hospital
Nanjing, 210006
Qian Li
Zhongda Hospital Southeast University
Nanjing, 210009
Ling Li
Shanghai Putuo District Center Hospital
Shanghai, 200062
Zongjun Liu
Jiading District Central Hospital
Shanghai, 201800
Lixia Suo
The Third Hospital of Hebei Medical University
Shijiazhuang, 050051
Yanqing Chi
Hebei General Hospital
Shijiazhuang, 500051
Luping Ren
Tianjin Medical University General Hospital
Tianjin, 300052
18322017516
Ming Liu
The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, 315100
13806542929
Chaoming Wu
The Affiliated Hospital of Xuzhou Medical College
Xuzhou, 221006
Hong Zhu
The Second People's Hospital of Yibin
Yibin, 644000
Chenli Zhang
Zigong First People's Hospital
Zigong, 643000
Jian Li
Italy17 sites
Azienda USL 8 di Arezzo
Arezzo, 52100
Alessia Scatena
Ospedale di Baggiovara
Baggiovara, 41126
0593962453
Vincenzo Rochira
IRCCS - AOU di Bologna
Bologna, 40138
39 0512144190
Uberto Pagotto
Osepdale Civile Fr 5
Ceccano, 03023
+39 06225419151
Nicola Napoli
Università degli Studi Gabriele D' Annunzio
Chieti, 66100
0871541322
Francesca Santilli
Azienda Ospedaliera Universitaria Careggi
Florence, 50134
055 7946514
Edoardo Mannucci
Ospedale San Raffaele
Milan, 20132
0226432819
Emanuela Setola
University of Naples Federico II
Naples, 80131
Antonio Cittadini
Azienda Ospedale - Università Padova
Padova, 35128
GianPaolo Fadini
A.O.U. Policlinico Paolo Giaccone
Palermo, 90127
39 091 6552251
Silvio Buscemi
Azienda Ospedaliero Universitaria di Parma
Parma, 43126
Alessandra Dei Cas
Azienda Ospedaliera Universitaria Pisana
Pisa, 56124
39050995001
Ferruccio Santini
IRCCS San Raffaele Roma
Roma, 00166
Massimiliano Caprio
Azienda Ospedaliera Sant'Andrea
Roma, 00189
Giorgio Sesti
IRCCS Istituto Clinico Humanitas
Rozzano, 20089
+390282247222
Marco Mirani
Ospedale Le Scotte
Siena, 53100
00390577585406
Maria Grazia Castagna
ASL Città di Torino
Torino, 10122
Salvatore Oleandri
Brazil15 sites
Centro de Pesquisa Clinica do Coracao
Aracaju, 49055-530
557999987-0794
FÁBIO SILVEIRA
Centro de Pesquisa Clinica do Brasil
Brasília, 71625-175
556133643364
Joao Lindolfo Borges
Centro de Pesquisa Sao Lucas
Campinas, 13060-803
55 19 3343-8688
Danilo Villagelin Neto
Quanta Diagnóstico e Terapia
Curitiba, 80045170
5541999736442
Rosangela Rea
Instituto de Ensino e Pesquisa Clinica do Ceara
Fortaleza, 60125058
00558532579646
Maria Cerqueira
Private Practice - Dr.Miguel N. Hissa
Fortaleza, 60430-350
55 85 3214.6530
Miguel Hissa
Núcleo de Pesquisa Clínica do Rio Grande do Sul
Porto Alegre, 90430-001
555137796400
Luis Henrique Canani
Hospital Moinhos de Vento
Porto Alegre, 90560032
55 (51) 3537-8258
Tiago Schuch
Rede AME SAÚDE
Recife, 50720-110
Audes Feitosa
IBPClin - Instituto Brasil de Pesquisa Clínica
Rio de Janeiro, 20241-180
552125277979
Renata Alexandra Pinheiro
Instituto de Pesquisa Clinica
São Paulo, 01223-001
Christiani Poço
CPHosp Medicina, Ensino e Pesquisa (CPQuali)
São Paulo, 01228-000
55 11 2776-6801
Gustavo Augusto
CPCLIN
São Paulo, 01228-200
551126303777
Denise Franco
CEPIC - Centro Paulista de Investigação Clínica
São Paulo, 04266-010
551122713450
Breno Balabem Alves
CEDOES
Vitória, 29055450
552721250202
Rachel Armani
Mexico15 sites
Centro de Atencion al Diabetico Actopan
Actopan, 42500
Patricia Nuriulu Escobar
Investigación Clínica Cuernavaca, S.C.
Cuernavaca, 62448
+527772024934
Ivan Lopez Paz
Centro Para El Desarrollo de La Medicina Y de Asistencia Medica Especializada S.C.
Culiacán, 80230
Ricardo Borrego Montoya
Lahoja. Asociacion Para La Investigacion Y La Farmacovigilancia
Durango, 34000
+52 6188114091
Juan Núñez Fragoso
Diseno y Planeacion en Investigacion Medica - Guadalajara - Calle Amado Nervo
Guadalajara, 44600
5233305493
Cesar Calvo Vargas
Instituto Cardiovascular de León S.C.
León, 37530
52 477 2582008
Luis Venegas Carrillo
Instituto Nacional de Cardiologia Ignacio Chavez
México, 14080
52 55 35661465
Jose Lopez Gil
Centro de Investigación Clinica Chapultepec
Mexico City, 04100
5560660026
Jose Gotes Palazuelos
Gastrobariátrica Santa Fe
Mexico City, 05348
Juan Mauricio Vera Zertuche
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
Mexico City, 11650
52 5585340943
Melchor Alpizar Salazar
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, 14080
+525579597066
Ricardo Correa-Rotter
Servicios de Oncologia Medica Integral, S.A. de C.V. Sucursal Renal
Monterrey, 64060
Jesus Villarreal
UBAM Unidad Biomedica Avanzada Monterrey
Monterrey, 64460
8113578896
Raymundo García Reza
Centro de investigación y control metabólico
Monterrey, 66465
81 83488973
Víctor Castelán Vargas
Centro de Estudios Clínicos de Querétaro (CECLIQ)
Querétaro, 76000
4422153067
Marco Alcocer Gamba
South Korea15 sites
The Catholic University of Korea, Bucheon St. Mary's Hospital
Bucheon-si, 14647
Jang Won Son
Kosin University Gospel Hospital
Busan, 49267
Bukyung Kim
Hanyang University Guri Hospital
Guri-si, 11923
Chang Beom Lee
Chosun University Hospital
Gwangju, 61453
Sang Yong Kim
Yeungnam Univeristy Medical Center
Gyeongsan-si, 42415
82-10-9370-3846
KYUCHANG WON
Inha University Hospital
Incheon, 22332
So Hun Kim
Konyang University Hospital
Seogu, 35365
Geun Yong Park
Seoul National University Bundang Hospital
Seongnam, 13620
Soo Lim
Nowon Eulji Medical Center, Eulji University
Seoul, 01830
1093908214
kyungwan Min
Korea University Anam Hospital
Seoul, 02841
Sin Gon Kim
Severance Hospital, Yonsei University Health System
Seoul, 03722
Byung Wan Lee
Asan Medical Center
Seoul, 05505
Se Hee Min
The Catholic Univ. of Korea Seoul St. Mary's Hospital
Seoul, 06591
Eun Young Lee
Ulsan University Hospital
Ulsan, 44033
01032352748
ILSEONG NAMGOONG
Yonsei University-Wonju Severance Christian Hospital
Wŏnju, 26426
033-741-1248
Choon Hee Chung
Spain14 sites
CHUAC-Complejo Hospitalario Universitario A Coruña
A Coruña, 15006
655624017
Alfonso Soto Gonzalez
Hospital Universitario de La Ribera
Alzira, 46600
34657845358
carmen fajardo
Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval
Ferrol, 15405
34981454513
DIEGO BELLIDO GUERRERO
Hospital Vithas La Salud
Granada, 18008
658011529
Cristobal Morales Portillo
Hospital Ribera Polusa
Lugo, 27004
982 22 28 54
Secundino Cigarran
Hospital Universitario La Paz
Madrid, 28046
+ 34 699924659
ALMUDENA CASTRO
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, 28222
911916000
Maria Marques Vidas
Hospital Universitari Son Espases
Palma, 07120
34 871 205256
Santiago Tofe Povedano
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, 28223
34914522000
Esteban Jodar Gimeno
Hospital Universitario Marqués de Valdecilla
Santander, 39008
34639659866
Luis Vazquez Salvi
Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)
Seville, 41003
+ 34 954709183
Alberto Aliaga Verdugo
Hospital Universitario Virgen Del Rocio
Seville, 41013
955012000
Virginia Bellido
Vithas Hospital Sevilla
Seville, 41950
658011529
Cristobal Morales Portillo
Hospital Clinico de Valencia
Valencia, 46010
Jose Gorriz
France12 sites
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106
Coralie AMADOU
Chu Grenoble Alpes
La Tronche, 38700
0476765517
Pierre-Louis Carron
Centre Hospitalier Louis Pasteur
Le Coudray, 28630
0237334299
Mariana Barbat
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
Nantes, 44093 Cedex 1
Simon VILLE
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes
Nantes, 44093
33 2 53 48 27 01
david jacobi
Hôpital Européen Georges Pompidou
Paris, 75015
3356095517
Sebastien CZERNICHOW
Hôpital Bichat - Claude-Bernard
Paris, 75018
+33140258880
louis potier
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69494 Cédex
33 4 78 86 14 87
Emmanuel DISSE
Centre Hospitalier Universitaire de Poitiers
Poitiers, 86021
Claire BOULETI
CHU Charles Nicolle
Rouen, 76031
Eric Durand
CHU Rangueil
Toulouse, 31059
33 5 61 32 30 18
Pierre Gourdy
Groupe Hospitalier Mutualiste Les Portes du Sud
Vénissieux, 69200
33607527530
Chantal Bully
Germany12 sites
FutureMeds Berlin
Berlin, 10629
+49 30 439741 239
Peter Hahn
Private Practice - Dr. Andrea Rinke
Bochum, 44789
004923460144350
Andrea Rinke
ZKS Suedbrandenburg
Elsterwerda, 04910
49-3533-489721
Andreas Hagenow
ClinPhenomics CVC GmbH
Frankfurt, 60596
06957702866
Martin Duersch
UKSH Campus Lübeck, Med. 1 - AG Meyhöfer
Lübeck, 23562
49451 50075673
Svenja Meyhöfer
CRS Clinical Research Services Mannheim
Mannheim, 68167
004962115045279
Thomas Forst
FutureMeds Offenbach
Offenbach, 63065
0049 69 247433849
Christel Contzen
RED-Institut GmbH
Oldenburg, 23758
0049436150630128
Thomas Schaum
Ceda-Research
Pohlheim, 35415
01722074613
Joachim van Gellecom
Marienhospital Stuttgart
Stuttgart, 70199
0049711-6489-2102
Monika Kellerer
Nephrologisches Zentrum Villingen-Schwenningen
Villingen-Schwenningen, 78052
0049772199850
Martina Guthoff
Medislim GmbH
Weinheim, 69469
0049620112080
Beate Moeckesch
Turkey (Türkiye)12 sites
Çukurova Üniversitesi Tıp Fakültesi Adana Hastanesi
Adana, 01330
05327656585
Bekir Tamer Tetiker
Ankara Etlik City Hospital
Ankara, 06170
905320521426
Hakan Gullu
Ankara Bilkent Şehir Hastanesi
Ankara, 06800
Ihsan ATES
Hacettepe Universite Hastaneleri
Ankara
0905333272917
MUSTAFA ARICI
Akdeniz Universitesi Hastanesi
Antalya, 07070
90 5337670913
Ramazan Sari
Dicle Üniversitesi
Diyarbakır, 21100
05523163206
ALPASLAN TUZCU
Eskisehir Osmangazi University
Eskişehir, 26480
Yuksel Cavusoglu
Istanbul University Cerrahpasa Medical School Internal Diseases Institute
Istanbul, 34098
Nurhan Seyahi
Erciyes Universitesi Tıp Fakultesi Hastaneleri
Kayseri, 380380
90 530 346 22 10
Ismail Kocyigit
Kocaeli Üniversitesi
Kocaeli, 41380
905554512188
Tayfun Sahin
Kocaeli Üniversitesi
Kocaeli, 41380
05076771924
Necmi Eren
Baskent University Dr. Turgut Noyan Research and Training Center
Yüreğir, 01250
0905333208241
Okan Bakiner
Australia11 sites
Nightingale Research
Adelaide, 5000
Andrew Hamilton
Box Hill Hospital
Box Hill, 3128
0390926753
Rosemary Wong
Royal Brisbane and Women's Hospital
Brisbane, 4029
+61736468111
Donald McLeod
Nightingale Research - Frankston
Frankston, 3199
Olivier van den Brink
Canberra Hospital
Garran, 2605
0251242821
Richard Singer
Ipswich Hospital
Ipswich, 4305
0402112100
Thomas Dover
Life Clinical Research
Ipswich, 4305
Andrew McCann
Momentum Sunshine
Melbourne, 3021
0395096166
King Cheung
Paratus Clinical Research - Melbourne
Melbourne, 3070
Kianoosh Noori Samie
Royal North Shore Hospital
St Leonards, 2065
Sarah Glastras
Innovate Clinical Research
Waitara, 2077
Rachel Graham
Canada11 sites
Centricity Research Brampton Endocrinology
Brampton, L6S 0C6
905 595 0560
Harpreet Bajaj
Well Health Diagnostic Center- Brampton Center
Brampton, L6W 2X7
2894046123
Ursula Jurt
C-health Research
Calgary, T2V 4J2
Shaheed Sorathia
NSHA-QEII Health Sciences Centre-Dickson Bldg
Halifax, B3H 1V7
9024733106
Thomas Ransom
Kelowna Health and Memory Centre
Kelowna, V1Y 5A8
Colleen Maytham
Endocrinologie Oasis
Montreal, H4J 1E3
1 (514) 442-0791
Zeina Yared
Centricity Research Pointe-Claire Multispecialty
Pointe-Claire, H9R 4S3
514-694-9940
Waheed Rehman
IUCPQ
Québec, G1V 4G5
Olivier Bertrand
NL Health Services
St. John's, A1B 3V6
7097775976
Sahar Iqbal
Centre de Medecine Metabolique de Lanaudiere (CMML)
Terrebonne, J6X 4P7
5149075101
Yves Robitaille
Clinical Research Solutions - Kitchener
Waterloo, N2T 0C1
519 743 2573
Shivinder Jolly
Japan10 sites
NewHeart Watanabe Institute
Hamadayama, Suginami-ku, 168-0065
81120023812
Tatsuya Sugimoto
Hyogo Prefectural Harima-Himeji General Medical Center
Himeji, 670-8560
81120023812
NAOKO HASHIMOTO
Kimitsu Chuo Hospital
Kisarazu, 292-8535
81120023812
Ryoichi Ishibashi
Seino Internal Medicine Clinic
Kōriyama, 963-8851
81120023812
Hiroaki Seino
Jinnouchi Hospital
Kumamoto, 862-0976
81120023812
Hideaki Jinnouchi
St. Mary's Hospital
Kurume, 830-8543
81120023812
Yuji Uchizono
Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai
Osaka, 530-8480
81120023812
Akihiro Hamasaki
Yasuda Diabetes Clinic
Osaka, 536-0002
81120023812
Koichiro Yasuda
Yotsuya Internal Medicine Clinic
Shinjyuku, 160-0017
81120023812
takahiro yokoyama
Uji-Tokushukai Medical Center
Uji, 611-0041
81120023812
Atsushi Sueyoshi
Romania10 sites
CMI Dr.Pletea Noemi SRL
Bacau, 600154
40744775762
NOEMI PLETEA
Private Practice - Dr. Mercea Corina Delia
Baia Mare, 430123
0723090107
DELIA MERCEA
Futuremeds - Brașov
Brasov, 500299
+40 722 566 616
Ioana-Emilia Ferariu
Geea Medical Easy Diet
Bucharest, 010627
40314288633
Georgeta Vacaru
Futuremeds - București
Bucharest, 031441
+40 723 680 497
Oana-Andreea Parliteanu
Futuremeds - Craiova
Craiova, 200515
40763670811
Ionela Mihaela Vladu
Futuremeds - Galați
Galați, 800183
0040724405355
Cristina-Victoria Mistodie
Gama Diamed
Mangalia, 905500
0040241740581
Amalia Thury-Burileanu
Clinica Korall
Satu Mare, 440055
40746013882
Adriana Filimon
Rinart Diab SRL
Targoviste, 130168
0040724372432
Anca Nicoara
Ukraine10 sites
Regional Communal Non-commercial enterprise "Chernivtsi regional clinical hospital"
Chernivtsi, 58000
380506604554
Nataliia Pashkovska
Clinical Diagnostic Center
Ivano-Frankivsk, 76018
+380986445126
Vadym Berenfus
Institute of Endocrinology and Metabolism named after Komissarenko
Kiev, 04114
+380976444044
Olesia Zinych
Edelweiss Medics
Kyiv, 02002
+380445949200
Oleksandra Tymofeieva
Medbud Clinic
Kyiv, 03037
380445947078
Svitlana Postol
ARTEM
Kyiv, 04050
380632355558
Borys Mankovsky
Lviv City Clinical Hospital #4
Lviv, 79011
Bohdan Chulovskyi
Zakarpattia Endoclinic
Uzhhorod, 88000
+380505191209
Olga Oleksyk
Vinnytsia Regional Clinical Endocrinology Dispensary
Vinnytsia, 21010
+380432531735
Maryna Vlasenko
"University Clinic" of Vinnytsia National Memorial Medical University n.a. M.I.Pyrohov (Treatment-educatio -T
Vinnytsia, 21029
Sergii Shevchuk
Hungary8 sites
DRC Gyógyszervizsgáló Központ
Balatonfüred, 8230
3687481616
Jozsef Pauer
Semmelweis University
Budapest, 1122
3614586840
Béla Merkely
Strazsahegy Medicina Bt.
Budapest, H1171
36309214740
Miklos Kajetan
Debreceni Egyetem Klinikai Központ
Debrecen, 4031
36306630741
Gizella Petro
Debreceni Egyetem Klinikai Kozpont
Debrecen, 4032
0036309657913
Denes Pall
Nagykanizsai Kanizsai Dorottya Korhaz
Nagykanizsa, 8800
Tunde Balint
Medifarma 98 Kft
Nyíregyháza, 4400
0036209530430
Zsolt Zilahi
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ
Szeged, 6725
36204986434
Robert Takacs
India8 sites
KLES Dr. Prabhakar Kore Hospital & M.R.C
Belagavi, 590010
0831-240700
Sanjay Kumar Porwal
Endolife Speciality Hospitals
Guntur, 522001
Anjith VUPPUTURI
Gauhati Medical College and Hospital
Guwahati, 781032
Farhin Iqbal
King Edward Memorial Hospital & Seth Gordhandas Sunderdas Medical College
Mumbai, 400012
91 97691 33740
Charan Lanjewar
Kingsway Hospitals (Best Multispeciality Hospital in Nagpur)
Nagpur, 440001
Rishi Lohiya
Arogyaseva Medical Academy of India - Ace Hospital
Pune, 411004
9619284398
Hemant Kokane
All India Institute of Medical Sciences - Rishikesh
Rishikesh, 249203
Barun Kumar
Nirmal Hospital Pvt Ltd.
Surat, 395002
Pritesh Parekh
Czechia6 sites
Interni a diabetologicka ordinace, s.r.o.
Náchod, 547 01
420 491 424 191
Petra Sejvlova
Nemocnice AGEL Novy Jicin a.s.
Nový Jičín, 74101
+420723098731
Vaclava Honova
EUC Klinika Praha
Prague, 150 00
420257288617
Katarina Halciakova
Praglandia s.r.o
Prague, 150 00
420731586736
Vaclav Pavlinak
Nemocnice Roudnice nad Labem
Roudnice nad Labem, 413 01
00420775355153
Andrej Bajo
Dia doktor
Ústí nad Labem, 400 07
Petra Siroka
Poland6 sites
Uniwersytecki Szpital Kliniczny w Białymstoku
Bialystok, 15-276
+48 85 831 8130
Anna Poplawska-Kita
Nova Reuma Domyslawska i Rusilowicz Spolka Partnerska Lekarza Reumatologa i Fizjoterapeuty
Bialystok, 15-707
+48 513172646
Irena Glowinska
Linden sp. z o. o. sp. k.
Krakow, 30-105
+48693643789
Katarzyna Palka
Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczne DIAB-ENDO-MET
Krakow, 31-261
48126237122
Joanna Mirocka
Drelich Grzegorz Centrum Kardiologiczne Kardio-Med
Lublin, 20-518
48 601 651 647
Grzegorz Drelich
IRMED
Piotrkow Trybunalski, 97-300
48447890484
TOMASZ CIURUS
Puerto Rico3 sites
Puerto Rico Health and Wellness Institute
Dorado, 00646
7877961049
Elham Ghorbani
Puerto Rico Medical Research
Ponce, 00717
787-284-5366
Jose Santiago
Mgcendo Llc
San Juan, 00921
7874842757
Martha Gomez-Cuellar
About this study
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once-Weekly Eloralintide in Adult Participants With Obesity or Overweight, Type 2 Diabetes, and Increased CV Risk
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with a placebo in participants with obesity or overweight, type 2 diabetes, and increased cardiovascular risk.
- Being tested
- Eloralintide, Placebo
- Medical subject headings
- Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EloralintideDrug
Also called LY3841136
Administered SC
PlaceboDrug
Administered SC
| Study group | Role | What they receive |
|---|---|---|
| Eloralintide | Experimental | Participants will receive eloralintide subcutaneously (SC) Receives: Drug: Eloralintide |
| Placebo | Placebo comparator | Participants will receive placebo SC Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percent Change from Baseline in Body Weight
Measured: Baseline, Week 64
Change from Baseline in Hemoglobin A1c (HbA1c)
Measured: Baseline, Week 36
Secondary outcomes (9)
Change from Baseline in Waist-to-Height Ratio
Measured: Baseline, Week 64
Change from Baseline in Systolic Blood Pressure
Measured: Baseline, Week 36
Percent Change from Baseline in High-Sensitivity C-reactive Protein (hsCRP)
Measured: Baseline, Week 36
Percent Change from Baseline in Triglycerides
Measured: Baseline, Week 36
Change from Baseline in Body Mass Index (BMI)
Measured: Baseline, Week 64
Change from Baseline in Short Form-36 (SF-36 v2) Score
Measured: Baseline, Week 64
Change from Baseline in Estimated Glomerular Filtration Rate (eGFR)
Measured: Baseline, Week 64
Pharmacokinetics (PK): Maximum Concentration at Steady State (Cmax,ss)
Measured: Baseline through Week 64
PK: Area Under the Concentration Versus Time Curve for One Dosing Interval at Steady State (AUC(0-ᴛ)ss)
Measured: Baseline through Week 64
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2026
- Study startDec 2026 (estimated)
- Primary completionNov 2029 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by Eli Lilly and CompanyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 3,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Eli Lilly and Company
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Study director, Eli Lilly and Company
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07900633
- Sponsor's protocol ID
- 27870
- Other IDs
- J3R-MC-YDAS, 2026-525919-14-00
- Acronym
- ENLIGHTEN-10
- Status last verified
- Oct 2026
- First submitted
- 22 Oct 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once-Weekly Eloralintide in Adult Participants With Obesity or Overweight, Type 2 Diabetes, and Increased CV Risk
- ClinicalTrials.gov ID
- NCT07900633
- Acronym / sponsor ID
- ENLIGHTEN-10 / 27870
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 3,000 participants (estimated)
- Lead sponsor
- Eli Lilly and CompanyIndustry (pharma, biotech, devices)
- Study start
- Dec 2026 (estimated)
- Primary completion
- Nov 2029 (estimated)
- Study completion
- Dec 2029 (estimated)
- First posted
- 28 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with a placebo in participants with obesity or overweight, type 2 diabetes, and increased cardiovascular risk.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Eloralintide | Experimental | Drug: EloralintideParticipants will receive eloralintide subcutaneously (SC) |
| Placebo | Placebo comparator | Drug: PlaceboParticipants will receive placebo SC |
Who may qualify
- Ages
- 45 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Have type 2 diabetes
- Have a HbA1c value between ≥ 6.5% and ≤ 9.5% at screening
- Are on stable treatment with an unchanged dose of at least 1 and no more than 4 antihyperglycemic therapies for at least 90 days before screening
- Have an increased risk of cardiovascular events
- Have a BMI ≥ 25.0 kg/m2 at screening
Key exclusion criteria (10 listed)
- Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed >1 year before screening)
- Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
- Have type 1 diabetes
- Have a history or diagnosis of New York Heart Association Functional Classification IV congestive heart failure
- Have had within 60 days prior to screening:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EloralintideAlso: LY3841136Administered SC | Drug | Eloralintide |
| PlaceboAdministered SC | Drug | Placebo |
Primary outcome
Percent Change from Baseline in Body Weight
Time frame: Baseline, Week 64
Change from Baseline in Hemoglobin A1c (HbA1c)
Time frame: Baseline, Week 36
9 secondary outcomes
Change from Baseline in Waist-to-Height Ratio
Time frame: Baseline, Week 64
Change from Baseline in Systolic Blood Pressure
Time frame: Baseline, Week 36
Percent Change from Baseline in High-Sensitivity C-reactive Protein (hsCRP)
Time frame: Baseline, Week 36
Percent Change from Baseline in Triglycerides
Time frame: Baseline, Week 36
Change from Baseline in Body Mass Index (BMI)
Time frame: Baseline, Week 64
Change from Baseline in Short Form-36 (SF-36 v2) Score
Time frame: Baseline, Week 64
Change from Baseline in Estimated Glomerular Filtration Rate (eGFR)
Time frame: Baseline, Week 64
Pharmacokinetics (PK): Maximum Concentration at Steady State (Cmax,ss)
Time frame: Baseline through Week 64
PK: Area Under the Concentration Versus Time Curve for One Dosing Interval at Steady State (AUC(0-ᴛ)ss)
Time frame: Baseline through Week 64
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- A clinical trial for adults with excess weight and type 2 diabetes who are at risk for heart attack or stroke (ENLIGHTEN-10)Link provided by the sponsor.
- Individual participant dataSharing planned: Yes. Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or contact
Physicians interested in becoming principal investigators please contact contact
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST) study director
Eli Lilly and Company
309 sites in 21 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Eloralintide in people with Obesity and Overweight, run by Eli Lilly and Company at 309 sites in 21 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 309 sites in United States, Argentina, China, Italy, Brazil and 16 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or (317-615-4559, LillyTrials@Lilly.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percent Change from Baseline in Body Weight (time frame: Baseline, Week 64). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.